Telix ProstACT Phase 3 Part 1 meets safety goals
Telix's TLX591-Tx combination therapy shows acceptable safety profile in mCRPC patients
Fred Hutch hematologists featured at 2026 Tandem Meetings
Fred Hutch scientists presented research on stem cell transplantation risks and gene expression changes during pre-transplant conditioning.
Large Study Links Healthier Diets to Lower Colorectal Cancer Risks
Research highlights the power of overall eating patterns, not just individual foods, in reducing cancer risk.